Media & Resources

Our comprehensive bank of media and resources, from news and events, to white papers and FAQs.

6th April 2020


Biocatalysts Ltd Launch a Microbial Alternative to Pancreatic Lipase

enzyme-manufacturing Enzyme specialists, Biocatalysts Ltd, announce the launch of their new enzyme Lipomod™ 888MDP. This non-genetically modified microbial lipase preparation is a suitable alternative to pancreatic lipase and due to its microbial origin, it is both Kosher and Halal, as well as being vegetarian, vegan and GMO VLOG compliant.

Pancreatic lipase is derived from the pancreas of pigs and is widely used in a number of food processes where the hydrolysis of fats is required; from improving the flavour characteristic in enzyme modified cheese (EMC) to releasing the fatty acids from the glycerol backbone of lard or tallow generating savoury meaty flavours in pet foods. Due to the continued worldwide spread of African Swine Fever (ASF) the supply and quality of pancreatic lipase has become an issue, to overcome this Biocatalysts have developed a microbial alternative, Lipomod™ 888MDP (L888MDP).
Comparative to pancreatic lipase, L888MDP is a fungal lipase enzyme preparation. It is particularly suitable for the hydrolysis of animal fats, breaking down the triglycerides to liberate fatty acids to produce strong flavour characteristics. L888MDP is active against all 3 positions on the triglyceride molecule, making it suitable for hydrolysis of complex fats to enhance flavours for palatants applications.

This product is an addition to Biocatalyst’s extensive range of microbial enzymes, which have been developed to meet the growing demand for clean label products.
For further information or to arrange a sample of L888MDP please contact Biocatalysts on or alternatively view the website